Dupilumab for Eosinophilic Esophagitis With Severe Strictures

NCT06352073 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Esophagitis
EoE

Interventions

DRUG: Dupilumab

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]